US health care company Johnson & Johnson (J&J) has become the latest global firm accused of misconduct in China after a court ordered it to pay $85,000 for compensation to a local distributor in a lawsuit brought under an anti-monopoly law.

The ruling by a Shanghai court expands use of the five-year-old law and comes amid a flurry of investigations of possible bribery, price-fixing and other misconduct by global firms on the mainland. The court said J&J was guilty of “vertical monopoly” for setting minimum prices for surgical sutures.